Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced today it has expanded its General Care Solution, which comprises patient monitors, wearable biosensors, and clinical decision support algorithms, with the new Philips IntelliVue GuardianSoftware mobile client application. The mobile app has received 510(k) clearance from the US Food and Drug Administration (FDA) and leverages the capabilities of Philips’ General Care solution, which includes Early Warning Scoring (EWS), to provide clinicians with the benefit of mobility and optimized workflows.
In some hospital medical-surgical units, patient information and color coded early warning scores are written on a centrally located whiteboard used to notify clinicians of changes in patient status. This can sometimes lead to inefficiencies and delays in care as clinicians are not receiving important updates in real-time. With the introduction of the IntelliVue GuardianSoftware mobile client application, clinicians can now view patient vital signs, collected via compatible devices like the wearable biosensor, and early warning scores on their mobile devices. The IntelliVue GuardianSoftware mobile client application can help notify clinicians to signs of potential patient deterioration before an adverse event might occur, supporting them to more efficiently intervene and focus on those patients who need their attention.
